HOME >> MEDICINE >> NEWS
GSK's Pazopanib shows positive results in patients with advanced renal cell carcinoma

CHICAGO June 2, 2007 -- GlaxoSmithKline (GSK) today announced results from ongoing Phase II studies of pazopanib in advanced or metastatic renal cell carcinoma (RCC). These trials were presented at the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago. The results observed in these trials with pazopanib support further investigations.

Pazopanib is an oral, investigational angiogenesis inhibitor targeting vascular endothelial growth factor receptor (VEGFR), platelet-derived growth factor receptor (PDGFR) and c-kit, important proteins in the angiogenic process. Angiogenesis, which is the growth of new blood vessels in the body, plays a critical role in the growth and spread of tumors. ,

Renal cell carcinoma study (Abstract 5031)
DATA EMBARGOED UNTIL SATURDAY JUNE 2, 8AM CDT

This ongoing Phase II randomized discontinuation study is evaluating patients with advanced or metastatic RCC who have not received prior systemic therapy or have failed one prior therapy (cytokine or bevacizumab-containing regimen). All patients received 800 mg of pazopanib taken orally, once-daily during a 12 week lead-in period. Based on data available on 60 patients at the time of a planned interim analysis, the Independent Data Monitoring Committee (IDMC) recommended that randomization to placebo for patients with stable disease should be discontinued. The study continued as an open-label, single-arm study with all patients receiving pazopanib.

The preliminary week 12 response rate for all 225 patients was 27%. In addition, stable disease was achieved in 46% of patients for a total disease control rate of 73%. Responses have been observed beyond week 12, and the overall response rate will be reported at study completion. Response was determined according to RECIST (Response Evaluation Criteria In Solid Tumors) which is a set of published rules that defines when cancer patients improve
'"/>

Contact: Stephanie Gardner
steph.gardner@toniclc.com
020-779-89929
GAEA Initiative
2-Jun-2007


Page: 1 2 3

Related medicine news :

1. GSKs Pazopanib shows positive results in patients with advanced RCC and ovarian cancer
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Most seniors now have drug coverage, U-M study shows
4. Wireless technology shows promise in diagnosing pediatric intestinal disease
5. Study shows radiofrequency ablation highly effective in treating kidney tumors
6. Method shows promise for early detection of pancreatic cancer
7. Organic farming can feed the world, U-M study shows
8. New study shows Rescue Remedy is an effective all-natural stress, anxiety reliever
9. Borderline personality disorder shows improvements with intensive psychotherapy
10. New drug shows promise in treatment of advanced thyroid cancer
11. Study shows Diachrome improves blood sugar control in people with type 2 diabetes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2019)... PITTSBURGH (PRWEB) , ... August 21, 2019 , ... ... at Providence Point on Sunday, July 28. The Phase II expansion of Providence ... Providence Point campus, as well as construction of the 70-unit apartment tower, Hamilton ...
(Date:8/19/2019)... PORT SAINT LUCIE, Fla. (PRWEB) , ... August ... ... of ‘EminenStore.com’, an online platform selling Eminence Organic Skin Care products , ... EmStore.com’s President and CEO, Darlene DeVries, was a practicing esthetician in Florida providing ...
(Date:8/19/2019)... ... August 19, 2019 , ... ProRehab Louisville and Dr. ... preventative physical therapy and to access to top-notch sports medical care and sport injury ... understand the physical demands of ice skating, knows the individualized treatment plan, and understands ...
(Date:8/19/2019)... ... August 19, 2019 , ... A July 26 article ... be brushing their pets’ teeth twice a day. The acknowledges that, with dogs not ... suggests that close monitoring and brushing at least twice a week is likely enough ...
(Date:8/19/2019)... , ... August 18, 2019 , ... ... today launches its third product, Aqua+, adding two SKUs to its line of ... faster and more effectively than water alone. Distinguishing Aqua+ from other rehydration solutions ...
Breaking Medicine News(10 mins):
(Date:8/16/2019)... ... August 16, 2019 , ... Today, Point-of-Care Partners ... PharmD, PhD, has joined the company as a Government Affairs and Health IT ... and industry standards organizations to advance use of health IT for comprehensive medication ...
(Date:8/16/2019)... ... August 16, 2019 , ... ... prepare the kids for returning to the classroom. The National Pediculosis Association ... students can join their friends free of lice and their nits (lice eggs).     ...
(Date:8/15/2019)... ... August 15, 2019 , ... Men’s Health Memorial will celebrate the grand opening ... learn how to regain their strength and vitality. , “While many men may ... do something about it is not always easy,” said Robert A. Ochoa, MD, Medical ...
Breaking Medicine Technology:
Cached News: